Suppr超能文献

用于脓毒症管理的纳米平台:快速检测/预警、病原体清除及恢复免疫稳态

Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis.

作者信息

Luo Gan, Zhang Jue, Sun Yaqi, Wang Ya, Wang Hanbin, Cheng Baoli, Shu Qiang, Fang Xiangming

机构信息

Department of Anesthesiology and Intensive Care, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003 People's Republic of China.

National Clinical Research Center for Child Health, Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310052 People's Republic of China.

出版信息

Nanomicro Lett. 2021 Mar 8;13:88. doi: 10.1007/s40820-021-00598-3. eCollection 2021 Dec.

Abstract

Sepsis, a highly life-threatening organ dysfunction caused by uncontrollable immune responses to infection, is a leading contributor to mortality in intensive care units. Sepsis-related deaths have been reported to account for 19.7% of all global deaths. However, no effective and specific therapeutic for clinical sepsis management is available due to the complex pathogenesis. Concurrently eliminating infections and restoring immune homeostasis are regarded as the core strategies to manage sepsis. Sophisticated nanoplatforms guided by supramolecular and medicinal chemistry, targeting infection and/or imbalanced immune responses, have emerged as potent tools to combat sepsis by supporting more accurate diagnosis and precision treatment. Nanoplatforms can overcome the barriers faced by clinical strategies, including delayed diagnosis, drug resistance and incapacity to manage immune disorders. Here, we present a comprehensive review highlighting the pathogenetic characteristics of sepsis and future therapeutic concepts, summarizing the progress of these well-designed nanoplatforms in sepsis management and discussing the ongoing challenges and perspectives regarding future potential therapies. Based on these state-of-the-art studies, this review will advance multidisciplinary collaboration and drive clinical translation to remedy sepsis.

摘要

脓毒症是由对感染的失控免疫反应引起的一种高度危及生命的器官功能障碍,是重症监护病房死亡的主要原因。据报道,脓毒症相关死亡占全球所有死亡人数的19.7%。然而,由于发病机制复杂,目前尚无有效的临床脓毒症治疗方法。同时消除感染和恢复免疫稳态被视为脓毒症治疗的核心策略。由超分子和药物化学引导的先进纳米平台,针对感染和/或免疫反应失衡,已成为通过支持更准确的诊断和精准治疗来对抗脓毒症的有力工具。纳米平台可以克服临床策略面临的障碍,包括诊断延迟、耐药性和无法管理免疫紊乱。在此,我们进行全面综述,强调脓毒症的发病特征和未来治疗理念,总结这些精心设计的纳米平台在脓毒症治疗方面的进展,并讨论未来潜在治疗方法面临的挑战和前景。基于这些前沿研究,本综述将推动多学科合作并促进临床转化以治疗脓毒症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/1cb9971ead1a/40820_2021_598_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验